Next earnings date: 8 Aug 2025

Lifecore Biomedical, Inc. – NASDAQ:LFCR
Lifecore Biomedical stock price today
Lifecore Biomedical stock price monthly change
Lifecore Biomedical stock price quarterly change
Lifecore Biomedical stock price yearly change
Lifecore Biomedical key metrics
Market Cap | 262.20M |
Enterprise value | 265.86M |
P/E | -1.65 |
EV/Sales | 0.97 |
EV/EBITDA | -3.77 |
Price/Sales | 0.41 |
Price/Book | 1.16 |
PEG ratio | N/A |
EPS | -3.39 |
Revenue | 159.84M |
EBITDA | -3.30M |
Income | -100.91M |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
Profit margin | -36.56% |
Oper. margin | -6.66% |
Gross margin | 16.1% |
EBIT margin | -6.66% |
EBITDA margin | -2.07% |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeLifecore Biomedical stock price history
Lifecore Biomedical stock forecast
Lifecore Biomedical financial statements
Feb 2022 | 53.07M | -12.85M | -24.21% |
---|---|---|---|
May 2022 | 47.62M | -36.47M | -76.58% |
Feb 2023 | 27.6M | -15.46M | -56.02% |
May 2023 | 31.54M | -36.13M | -114.53% |
Aug 2025 | 32.77M | -5.76M | -17.58% |
---|---|---|---|
Nov 2025 | 39.45M | 606.44K | 1.54% |
Feb 2026 | 42.16M | 2.42M | 5.75% |
May 2026 | 46.92M | 5.45M | 11.63% |
Analysts Price target
Financials & Ratios estimates
2024-05-24 | -0.23 | 0.427 |
---|---|---|
2024-08-09 | -0.12 | -0.41 |
2024-08-26 | -0.12 | -0.15 |
Aug 2022 | 285800000 | 188.90M | 66.1% |
---|---|---|---|
Nov 2022 | 279073000 | 204.90M | 73.42% |
Feb 2023 | 236153000 | 201.94M | 85.51% |
May 2023 | 255150000 | 256.99M | 100.72% |
Feb 2022 | -20.12M | 67.98M | -47.09M |
---|---|---|---|
May 2022 | 35.99K | -19.38M | 19.14M |
Feb 2023 | -12.68M | 6.39M | 6.08M |
May 2023 | -17.28M | -7.5M | 20.90M |
Lifecore Biomedical alternative data
Sep 2023 | 689 |
---|---|
Oct 2023 | 689 |
Nov 2023 | 689 |
Dec 2023 | 689 |
Jan 2024 | 689 |
Feb 2024 | 689 |
Mar 2024 | 459 |
Apr 2024 | 459 |
May 2024 | 459 |
Jun 2024 | 459 |
Jul 2024 | 459 |
Lifecore Biomedical other data
Period | Buy | Sel |
---|---|---|
Oct 2024 | 1756097 | 0 |
Transaction | Date | Insider | Security | Shares | Price per share | Total value | Source |
---|---|---|---|---|---|---|---|
Option | LAKE RYAN DAVID officer: Chief Fi.. | Common Stock | 75,000 | N/A | N/A | ||
Purchase | WYNNEFIELD PARTNERS SMALL CAP VALUE LP I 10 percent owner | Common Stock, $0.001 par value per share | 169,753 | $4.1 | $695,987 | ||
Purchase | WYNNEFIELD PARTNERS SMALL CAP VALUE LP I 10 percent owner | Common Stock, $0.001 par value per share | 122,930 | $4.1 | $504,013 | ||
Purchase | KIPER CHRISTOPHER S director, 10 percent owner: | Common Stock | 1,311,312 | $4.1 | $5,376,379 | ||
Purchase | KIPER CHRISTOPHER S director, 10 percent owner: | Common Stock | 152,102 | $4.1 | $623,618 | ||
Option | CALLOWAY NATHANIEL director | Common Stock | 3,981 | N/A | N/A | ||
Option | CALLOWAY NATHANIEL director | Restricted Stock Unit | 3,981 | N/A | N/A | ||
Option | OBUS NELSON director | Common Stock | 9,554 | N/A | N/A | ||
Option | OBUS NELSON director | Restricted Stock Unit | 9,554 | N/A | N/A | ||
Option | EDWARDS JEFFREY L director | Common Stock | 9,554 | N/A | N/A |
Quarter | Transcript |
---|---|
Q4 2023 31 Aug 2023 | Q4 2023 Earnings Call Transcript |
Q3 2023 1 Jun 2023 | Q3 2023 Earnings Call Transcript |
Stock Picks From Seeking Alpha's June 2025 New Analysts
Lifecore Biomedical: Inflecting Financials Over Next 3 Years
Greenhaven Road Capital Main Fund Q1 2025 Top 5 Holdings
Laughing Water Capital Top 5 Investments (Q1 2025)
Rare Buy Picks In June 2023 - From 34 Discerning Analysts
Lifecore: Highly Skewed Special Situation
Lifecore Biomedical: Potential Company Sale
Lifecore: Extraordinary Upside Likely Despite Bankruptcy Concerns
-
What's the price of Lifecore Biomedical stock today?
One share of Lifecore Biomedical stock can currently be purchased for approximately $7.25.
-
When is Lifecore Biomedical's next earnings date?
Lifecore Biomedical, Inc. is estimated to report earnings on Friday, 8 Aug 2025.
-
Does Lifecore Biomedical pay dividends?
No, Lifecore Biomedical does not pay dividends.
-
How much money does Lifecore Biomedical make?
Lifecore Biomedical has a market capitalization of 262.20M and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 24.2% to 128.26M US dollars. Lifecore Biomedical earned 12.01M US dollars in net income (profit) last year or -$0.15 on an earnings per share basis.
-
What is Lifecore Biomedical's stock symbol?
Lifecore Biomedical, Inc. is traded on the NASDAQ under the ticker symbol "LFCR".
-
What is Lifecore Biomedical's primary industry?
Company operates in the Healthcare sector and Drug Manufacturers - Specialty & Generic industry.
-
How do i buy shares of Lifecore Biomedical?
Shares of Lifecore Biomedical can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
How many employees does Lifecore Biomedical have?
As Jul 2024, Lifecore Biomedical employs 459 workers.
-
When Lifecore Biomedical went public?
Lifecore Biomedical, Inc. is publicly traded company for more then 29 years since IPO on 15 Feb 1996.
-
What is Lifecore Biomedical's official website?
The official website for Lifecore Biomedical is lifecore.com.
-
Where are Lifecore Biomedical's headquarters?
Lifecore Biomedical is headquartered at 3515 Lyman Boulevard, Chaska, MN.
-
How can i contact Lifecore Biomedical?
Lifecore Biomedical's mailing address is 3515 Lyman Boulevard, Chaska, MN and company can be reached via phone at +95 2 368 4300.
Lifecore Biomedical company profile:

Lifecore Biomedical, Inc.
lifecore.comNASDAQ
524
Drug Manufacturers - Specialty & Generic
Healthcare
Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization in the United States and internationally. It operates through Lifecore, Curation Foods, and Other segments. The Lifecore segment engages in the manufacture of pharmaceutical-grade sodium hyaluronate (HA) in bulk form, as well as formulated and filled syringes and vials for injectable products used in treating a range of medical conditions and procedures. It also provides services, including technology development, material component changes, analytical method development, formulation development, pilot studies, stability studies, process validation, and production of materials for clinical studies to its partners for HA-based and non-HA based aseptically formulated and filled products. This segment sells its non-HA products for medical use primarily in the ophthalmic, orthopedic, and other markets. The Curation Foods segment engages in processing, marketing, and selling of olive oils and wine vinegars under the O brand; and guacamole and avocado food products under the Yucatan and Cabo Fresh brands, as well as various private labels. The company was formerly known as Landec Corporation and changed its name to Lifecore Biomedical, Inc. in November 2022. Lifecore Biomedical, Inc. was incorporated in 1986 and is headquartered in Santa Maria, California.
Chaska, MN 55318
CIK: 0001005286
ISIN: US5147661046
: